Singh, A.; Singh, P. TERIFLUNOMIDE: A NOVEL ORAL DISEASE-MODIFYING AGENT UNDER INVESTIGATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS. J. Drug Delivery Ther. 2016, 6 (5), 97-102. https://doi.org/10.22270/jddt.v6i5.1303.